Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Jan 13;530(1-2):103-6.
doi: 10.1016/j.ejphar.2005.11.032. Epub 2005 Dec 27.

Suppression of Feeding, Drinking, and Locomotion by a Putative Cannabinoid Receptor 'Silent Antagonist'

Affiliations
Comparative Study

Suppression of Feeding, Drinking, and Locomotion by a Putative Cannabinoid Receptor 'Silent Antagonist'

Andrew Gardner et al. Eur J Pharmacol. .

Abstract

This study compared the effects of the putative cannabinoid receptor 'silent antagonist' O-2050 with the cannabinoid receptor inverse agonist SR 141716 on food and water consumption, and locomotor activity. Non-deprived male Wistar rats were habituated to the apparatus and testing procedures, then injected intraperitoneally with vehicle, O-2050 (0.03-3.0 mg/kg), or SR 141716 (3.0 mg/kg) prior to 4-h test sessions. Food consumption was significantly reduced by both drugs. Water intake and locomotor activity were significantly reduced only by O-2050. Results support the notion that cannabinoid receptor antagonists suppress feeding behaviour by blocking an endogenous cannabinoid orexigenic signal, rather than by inverse agonism at cannabinoid receptors. However, further studies are needed to confirm the status of O-2050 as a cannabinoid CB(1) receptor antagonist devoid of inverse agonist properties.

Similar articles

See all similar articles

Cited by 24 articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

Feedback